<code id='E9DE13B86D'></code><style id='E9DE13B86D'></style>
    • <acronym id='E9DE13B86D'></acronym>
      <center id='E9DE13B86D'><center id='E9DE13B86D'><tfoot id='E9DE13B86D'></tfoot></center><abbr id='E9DE13B86D'><dir id='E9DE13B86D'><tfoot id='E9DE13B86D'></tfoot><noframes id='E9DE13B86D'>

    • <optgroup id='E9DE13B86D'><strike id='E9DE13B86D'><sup id='E9DE13B86D'></sup></strike><code id='E9DE13B86D'></code></optgroup>
        1. <b id='E9DE13B86D'><label id='E9DE13B86D'><select id='E9DE13B86D'><dt id='E9DE13B86D'><span id='E9DE13B86D'></span></dt></select></label></b><u id='E9DE13B86D'></u>
          <i id='E9DE13B86D'><strike id='E9DE13B86D'><tt id='E9DE13B86D'><pre id='E9DE13B86D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:16741
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          'Ancient DNA,' 23andMe reveal African American ancestries
          'Ancient DNA,' 23andMe reveal African American ancestries

          TheIsabellafurnacestackatCatoctinFurnace,nearFrederick,Md.CourtesyCamMillerNewresearchthatcombineste

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Biotech investment managers search for lucrative opportunities

          Fromleft,RodNathan,portfoliomanagerandpartnerofJ.Goldman&Co.;ARKInvestsenioranalystAliUrman;andP